We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Can AEHR Turn AI Processor Tests Into Long-Term Revenue Streams?
Read MoreHide Full Article
Key Takeaways
AEHR secured $22 million and $41 million in AI-related orders as processor testing demand expands.
AEHR is broadening its AI exposure through another processor supplier and a hyperscale customer.
AEHR expects fiscal 2027 revenue of $130 million-$150 million as AI testing production ramps up.
Aehr Test Systems, Inc. (AEHR - Free Report) is gaining traction in AI semiconductor testing as AI chips become more complex and costly. Its wafer-level burn-in technology allows manufacturers to screen devices before packaging, helping identify early-life failures while protecting costly components and advanced substrates. This is becoming increasingly relevant as AI infrastructure scales and processors enter high-volume production.
The opportunity is already translating into orders. In August 2026, AEHR received a $22 million follow-on order from its lead AI processor customer for FOX-XP wafer-level burn-in systems, with shipments expected within six months. The order followed a $14 million purchase in February, adding to earlier production momentum and reflecting the relationship’s move toward sustained production and broader deployment.
AEHR is also broadening its AI exposure beyond one customer. The company has reported successful wafer-level benchmark results with another major AI processor supplier, which is evaluating pilot production and an additional device. Its Sonoma platform is being deployed for package-level burn-in of high-power AI processors. In April, AEHR secured a record $41 million order from a hyperscale customer for custom AI ASIC burn-in.
The opportunity lies in turning these initial wins into recurring systems, WaferPak contactors and burn-in consumables as AI processor volumes expand. AEHR expects fiscal 2027 revenues of $130 million to $150 million, representing 2.6 to 3 times fiscal 2026 revenues. The company’s AI customer base is still developing, but follow-on orders and expanding production ramps suggest AI testing could evolve from a growth area into a durable revenue stream for AEHR.
AEHR Faces Stiff Competition
Aehr operates in a highly competitive semiconductor test equipment market, contending with strong rivals such as Teradyne, Inc. (TER - Free Report) and FormFactor, Inc. (FORM - Free Report) .
Teradyne is benefiting from strong AI-driven demand across compute and memory testing. TER reported Semiconductor Test revenues of $2.2 billion in the first half of 2026, supported by hyperscaler and AI infrastructure spending, while high-bandwidth memory (HBM) and DRAM testing add another growth avenue.
FormFactor is expanding its role in AI semiconductor testing through advanced probe cards and test solutions for HBM, advanced packaging and silicon photonics. Rising AI chip complexity is increasing test requirements, supporting demand for FORM’s precision testing capabilities across next-generation computing architectures.
AEHR’s shares have surged 111% over the past six months, outperforming the broader industry’s 14.3% growth.
Image Source: Zacks Investment Research
Aehr shares are trading at a premium. In terms of the forward 12-month price-to-sales (P/S), AEHR is trading at 17.51X, higher than the industry’s 5.54X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for AEHR’s fiscal 2027 earnings is pegged at 70 cents per share, a sharp increase from 3 cents a year ago.
View the Zacks #1 Rank List
Image: Bigstock
Can AEHR Turn AI Processor Tests Into Long-Term Revenue Streams?
Key Takeaways
Aehr Test Systems, Inc. (AEHR - Free Report) is gaining traction in AI semiconductor testing as AI chips become more complex and costly. Its wafer-level burn-in technology allows manufacturers to screen devices before packaging, helping identify early-life failures while protecting costly components and advanced substrates. This is becoming increasingly relevant as AI infrastructure scales and processors enter high-volume production.
The opportunity is already translating into orders. In August 2026, AEHR received a $22 million follow-on order from its lead AI processor customer for FOX-XP wafer-level burn-in systems, with shipments expected within six months. The order followed a $14 million purchase in February, adding to earlier production momentum and reflecting the relationship’s move toward sustained production and broader deployment.
AEHR is also broadening its AI exposure beyond one customer. The company has reported successful wafer-level benchmark results with another major AI processor supplier, which is evaluating pilot production and an additional device. Its Sonoma platform is being deployed for package-level burn-in of high-power AI processors. In April, AEHR secured a record $41 million order from a hyperscale customer for custom AI ASIC burn-in.
The opportunity lies in turning these initial wins into recurring systems, WaferPak contactors and burn-in consumables as AI processor volumes expand. AEHR expects fiscal 2027 revenues of $130 million to $150 million, representing 2.6 to 3 times fiscal 2026 revenues. The company’s AI customer base is still developing, but follow-on orders and expanding production ramps suggest AI testing could evolve from a growth area into a durable revenue stream for AEHR.
AEHR Faces Stiff Competition
Aehr operates in a highly competitive semiconductor test equipment market, contending with strong rivals such as Teradyne, Inc. (TER - Free Report) and FormFactor, Inc. (FORM - Free Report) .
Teradyne is benefiting from strong AI-driven demand across compute and memory testing. TER reported Semiconductor Test revenues of $2.2 billion in the first half of 2026, supported by hyperscaler and AI infrastructure spending, while high-bandwidth memory (HBM) and DRAM testing add another growth avenue.
FormFactor is expanding its role in AI semiconductor testing through advanced probe cards and test solutions for HBM, advanced packaging and silicon photonics. Rising AI chip complexity is increasing test requirements, supporting demand for FORM’s precision testing capabilities across next-generation computing architectures.
AEHR’s Share Price Performance, Valuation & Estimates
AEHR’s shares have surged 111% over the past six months, outperforming the broader industry’s 14.3% growth.
Image Source: Zacks Investment Research
Aehr shares are trading at a premium. In terms of the forward 12-month price-to-sales (P/S), AEHR is trading at 17.51X, higher than the industry’s 5.54X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for AEHR’s fiscal 2027 earnings is pegged at 70 cents per share, a sharp increase from 3 cents a year ago.
Image Source: Zacks Investment Research
Aehr currently carries a Zacks Rank#2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.